Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Net Margin of 16.47% for Q4 2025, down 455.0% year-over-year from 4.64% in Q4 2024, and up 6.98% quarter-over-quarter from 15.4% in Q3 2025.
Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Net Margin history runs 16 years deep, the most recent figure standing at 16.47% for Q4 2025.
- In Q4 2025, Net Margin fell 455.0% year-over-year to 16.47%; the TTM figure through Dec 2025 stood at 16.9% (down 223.0% YoY), while the FY2025 annual figure was 18.86%, up 26.0% from the prior year.
- Net Margin for Q4 2025 stood at 16.47%, up from 15.4% in the prior quarter.
- The five-year high for Net Margin was 21.46% in Q2 2021, with the low at 84.15% in Q1 2023.
- The 5-year median for Net Margin is 18.54% (2024), against an average of 13.18%.
- The sharpest annual moves came in 2023 and 2024: Net Margin sank 10366 bps in 2023, then surged 10200 bps in 2024.
- Prestige Consumer Healthcare's Net Margin stood at 18.3% in 2021, then grew by 3 bps to 18.86% in 2022, then decreased by 0 bps to 18.76% in 2023, then increased by 12 bps to 21.02% in 2024, then decreased by 22 bps to 16.47% in 2025.
- Business Quant data shows PBH's Net Margin at 16.47% in Q4 2025, 15.4% in Q3 2025, and 19.02% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.47% |
| Sep 30, 2025 | 15.40% |
| Jun 30, 2025 | 19.02% |
| Mar 31, 2025 | 16.91% |
| Dec 31, 2024 | 21.02% |
| Sep 30, 2024 | 19.16% |
| Jun 30, 2024 | 18.37% |
| Mar 31, 2024 | 17.86% |
| Dec 31, 2023 | 18.76% |
| Sep 30, 2023 | 18.71% |
| Jun 30, 2023 | 19.07% |
| Mar 31, 2023 | -84.15% |
| Dec 31, 2022 | 18.86% |
| Sep 30, 2022 | 17.64% |
| Jun 30, 2022 | 19.95% |
| Mar 31, 2022 | 19.51% |
| Dec 31, 2021 | 18.30% |
| Sep 30, 2021 | 16.41% |
| Jun 30, 2021 | 21.46% |
| Mar 31, 2021 | 14.94% |